gontivimab

Names

[ Name ]:
gontivimab

Biological Activity

[Description]:

Gontivimab (ALX-0171; VR-465) is a poent anti-RSV prefusion F protein nanobody with a KD value of 0.113 nM. Gontivimab shows antiviral activity. Gontivimab reduces the RSV load in the nose and lung[1].

[Related Catalog]:

Research Areas >> Infection

Signaling Pathways >> Anti-infection >> RSV

[Target]

KD: 0.113 nM (RSV prefusion F protein)[1]

[In Vitro]

Gontivimab (0-100000 nM) 显示出抗病毒活性，对 RSV-A、RSV-B 18537 菌株的 IC50 分别为 0.1、0.4 nM[1]。 Gontivimab 与 F 蛋白的抗原位点 II 结合[1]。

[In Vivo]

Gontivimab (1-68 mg/kg；鼻内给药或雾化) 降低大鼠鼻腔和肺部的 RSV 负荷[1]。 Animal Model: Rats (RSV Tracy)[1] Dosage: 1-68 mg/kg Administration: Intranasal administration or nebulization; once (day 2 or day 3) or twice (day 2 and day 3) Result: Resulted in significant viral load reductions in the lungs ranging.

[References]

[1]. Detalle L, et al. Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection. Antimicrob Agents Chemother. 2015 Oct 5;60(1):6-13.

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.